Simulations Plus, Inc.
Simulations Plus, Inc. (SLP) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
slp · pe ratio · data through Aug 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Simulations Plus, Inc. (SLP) measures how much investors pay for each dollar of the company's trailing earnings. SLP's current PE ratio of N/A is calculated by dividing its stock price of $15.91 by its TTM earnings per share of -$3.12.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-08-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%35.9x
MedianQ3 · 75%113.8x
Max
At N/A, SLP's current P/E is lower than in 0% of its annual fiscal year readings over the past 19 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Simulations Plus, Inc.You SLP | $321M | N/A | — | -$3.12 |
 AC Immune S.A. ACIU | $223M | N/A | — | -$0.70 |
 Agilon Health, Inc. AGL | $1.6B | N/A | — | -$24.48 |
 Alto Neuroscience, Inc. ANRO | $640M | N/A | — | -$2.19 |
 Cellectis S.A. CLLS | $294M | N/A | — | -$0.67 |
 Definitive Healthcare Corp. DH | $89M | N/A | — | -$1.30 |
 Korro Bio, Inc. KRRO | $105M | N/A | — | -$12.48 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-08-31Latest FY2025 | — | $-3.22 | — | |
2024-08-31 FY2024 | 72.79x | $0.50 | -18.8% | |
2023-08-31 FY2023 | 89.66x | $0.50 | -7.7% | |
2022-08-31 FY2022 | 97.15x | $0.62 | +7.0% | |
2021-08-31 FY2021 | 90.78x | $0.49 | -20.2% | |
2020-08-31 FY2020 | 113.77x | $0.52 | +54.6% | |
2019-08-31 FY2019 | 73.59x | $0.49 | +82.0% | |
2018-08-31 FY2018 | 40.44x | $0.52 | -6.4% | |
2017-08-31 FY2017 | 43.19x | $0.34 | +42.4% | |
2016-09-30 FY2016 | 30.34x | $0.29 | +2.4% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Simulations Plus, Inc. (SLP) measures how much investors pay for each dollar of the company's trailing earnings. SLP's current PE ratio of N/A is calculated by dividing its stock price of $15.91 by its TTM earnings per share of -$3.12.
Frequently asked questions
SLP pe ratio · 6 questionsSLP's current PE ratio is N/A as of 2026-06-09, based on a stock price of $15.91 and TTM EPS of -$3.12. Data sourced from Financial Modeling Prep via SLP's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Simulations Plus, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09